Verastem VSTM
Verastem: reports quarterly results
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001104659-26-092058
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Corvus Pharmaceuticals CRVS public float $252M, Jun 30, 2025
- DBV Technologies DBVT public float $251M, Jun 30, 2025
- Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025
- Annexon ANNX public float $244M, Jun 30, 2025
- Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
